Skip to main navigation Skip to search Skip to main content

Cross-Talk between LOX-1 and PCSK9 in vascular tissues

  • Zufeng Ding
  • , Shijie Liu
  • , Xianwei Wang
  • , Xiaoyan Deng
  • , Yubo Fan
  • , Jiwani Shahanawaz
  • , Robert J.Shmookler Reis
  • , Kattayi I. Varughese
  • , Tatsuya Sawamura
  • , Jawahar L. Mehta*
  • *Corresponding author for this work
  • University of Arkansas for Medical Sciences
  • Beihang University
  • Shinshu University

Research output: Contribution to journalArticlepeer-review

Abstract

Aims Lectin-like ox-LDL receptor-1 (LOX-1) plays an important role in inflammatory diseases, such as atherosclerosis. Proprotein convertase subtilisin/kexin type 9 (PCSK9) modulates LDL receptor degradation and influences serum LDL levels. The present study was designed to investigate the possible interaction between PCSK9 and LOX-1. Methods and results In the first set of experiments, human vascular endothelial cells and smooth muscle cells were studied at baseline and after lipopolysaccharide (LPS) treatment (to create an inflammatory state). Both PCSK9 and LOX-1 were strongly induced by LPS treatment. To define the role of PCSK9 in LOX-1 expression, cells were transfected with siRNA against PCSK9, which resulted in reduced LOX-1 expression and function. On the other hand, cells exposed to recombinant hPCSK9 revealed enhanced LOX-1 expression (P < 0.05). To determine whether LOX-1 also regulates PCSK9, cultured cells in which LOX-1 was knocked down by siRNA expressed less PCSK9, whereas those transfected with hLOX-1 cDNA showed increased PCSK9 expression. The second set of experiments was carried out in wild-Type (WT) and gene knockout (KO; LOX-1 and PCSK9) mice; LOX-1 KO mice showed much less PCSK9 (P < 0.05 vs. WT mice). PCSK9-KO mice showed much less LOX-1 (P < 0.05 vs. WT mice). Furthermore, we observed that mitochondrial reactive oxygen species (mtROS) plays an initiating role in the LOX-1/PCSK9 interaction, since mtROS induction enhanced and its inhibition reduced the expression of both PCSK9 and LOX-1.We also found that both LOX-1 and PCSK9 regulate adhesion molecules vascular cell adhesion molecule-1 expression. Finally, oxidized low-density lipoprotein and tumour necrosis factor-A, pro-inflammatory stimuli besides LPS, regulated PCSK9 expression that is mediated by the NF-kB signalling pathway. Conclusions These observations suggest that LOX-1 and PCSK9 positively influence each other's expression, especially during an inflammatory reaction. mtROS appear to be important initiators of PCSK9/LOX-1 expression.

Original languageEnglish
Pages (from-to)556-567
Number of pages12
JournalCardiovascular Research
Volume107
Issue number4
DOIs
StatePublished - 1 Sep 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • LOX-1
  • Mitochondrial ROS
  • PCSK9
  • VCAM-1

Fingerprint

Dive into the research topics of 'Cross-Talk between LOX-1 and PCSK9 in vascular tissues'. Together they form a unique fingerprint.

Cite this